Form D · Pharmaceuticals
Foment Bio, Inc.
Montgomery, TX · CIK 0002062787
Offering snapshot reported Mar 21, 2025 · SEC filing
- Reported sold
- $543K Offering amount: $1M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2025 | Initial | $542,550 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541691
Source: Form D, filed Mar 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ben Chlebina | Executive |
| Marc Penn | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
148 Wick Willow Rd
Montgomery, TX, 77356
Phone: 3309364211
Montgomery, TX, 77356
Phone: 3309364211